Swing Therapeutics
San Francisco, CA, United States · Biotechnology · 22 employees
Swing Therapeutics was founded in 2019 with the goal of developing digital treatments and services in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in
Funding history
- Seed — $3.3M — Sep 2025
- Venture - Series Unknown — $11.4M — Aug 2025
- Venture - Series Unknown — $10.3M — Jul 2022
- Venture - Series Unknown — $9.2M — Jul 2022
- Series A — $10.3M — Jun 2022
Recent signals
- Sep 15, 2025: Raised $3.3M in Seed
- Aug 29, 2025: Raised $11.4M in Venture - Series Unknown
- Jul 26, 2022: Raised $10.3M in Venture - Series Unknown
- Jul 26, 2022: Raised $9.2M in Venture - Series Unknown
- Jun 16, 2022: Raised $10.3M in Series A
See plans & pricing → Track Swing Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.